Search
for
Sort by
Research 151–180 of 1000+
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Alopecia areata and ritlecitinib: Unravelling response trajectories
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Update: baricitinib for alopecia areata
- At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
- Medicaid coverage of Janus kinase inhibitors for alopecia areata treatment
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- The Role of Janus Kinase Inhibitors in Dermatology
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- CURRENT UNDERSTANDING OF VITILIGO: A COMPREHENSIVE LITERATURE REVIEW
- The role of janus kinases in the treatment of autoimmune skin diseases
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Evolving treatment paradigms in dermatology: Insights from emerging and repurposed therapies
- Ottawa, Ontario, Canada, February 13–16, 2013
- Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Evaluating dermatologists’ knowledge of and attitudes toward Janus kinase inhibitor therapy for the treatment of alopecia areata
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- Are Janus kinase (JAK) inhibitors beneficial in the treatment of androgenic alopecia?
- Janus kinase inhibitors for alopecia areata: A narrative review